Komori
Earnings6092EnBio Holdings,IncInformation and Communications, Services and Others

Notice Concerning the Financial Results of an Unlisted Parent Company

Financial statements, shareholder composition, major shareholders and officer information for 株式会社シーアールイー, an other affiliated company of エンバイオ・ホールディングス, for the fiscal year ended January 2026 were disclosed. This disclosure does not present earnings forecasts or revisions to earnings forecasts for エンバイオ・ホールディングス itself.

Worth reading
—
Scored from 0 of 6 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Results for this period

Full year1 August 2025 to 31 January 2026Non-consolidated (standalone)
Net Sales23,353¥ million
Operating profit3,736¥ million
Ordinary income3,461¥ million
Net income attributable to owners of the parent2,330¥ million

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.

Financial position at period-end
Total assets173,925¥ million
of which net assets 37,749 ¥ million

The shaded area represents net assets as a proportion of total assets. It is calculated from the two amounts reported by the company.

Impairment loss¥27 million
Breakdown of extraordinary income (loss)Gain on sale of non-current assets ¥0 million, Loss on Disposal of Fixed Assets ¥8 million, Impairment Losses ¥27 million, Impairment Losses on Shares of Affiliates ¥51 million, Other ¥0 million
Treasury Shares at Period-End5,829,877 Shares
Results for this period
ItemDetails
Fiscal Period ClassificationFull year
Consolidated / non-consolidatedNon-consolidated (standalone)
Period Covered1 August 2025 to 31 January 2026
Net Sales¥23,353 million
Operating profit¥3,736 million
Ordinary income¥3,461 million
Profit attributable to owners of the parent¥2,330 million
Total assets¥173,925 million
Net assets¥37,749 million
Impairment loss¥27 million
Breakdown of extraordinary income (loss)Gain on sale of non-current assets ¥0 million, Loss on Disposal of Fixed Assets ¥8 million, Impairment Losses ¥27 million, Impairment Losses on Shares of Affiliates ¥51 million, Other ¥0 million
Treasury Shares at Period-End5,829,877 Shares
Items this document does not state (26)
Accounting standardsNet income per shareOperating MarginEquity ratioCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodFull-year earnings forecastRevision to Earnings ForecastAnnual Dividend ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogDepreciation and amortizationDisclosure regarding the going concern assumptionChange in accounting policyChanges in the scope of consolidationMaterial subsequent eventsAvailability of Supplementary Financial Results MaterialsAvailability of Financial Results BriefingIssued Shares at Period-EndFactors Behind Changes in Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To provide information on the financial results of 株式会社シーアールイー for the fiscal year ended January 2026.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning the Financial Results of an Unlisted Parent Company | EnBio Holdings,Inc (6092) timely disclosure | Komori